Priority 3 from the Mesothelioma PSP

UNCERTAINTY: What is the best way to monitor patients with diffuse pleural thickening and a negative biopsy who are considered to have a high risk of developing mesothelioma (e.g. repeat biopsies, imaging, etc)? (JLA PSP Priority 3)
Overall ranking 3
JLA question ID 0025/3 
Explanatory note Not available for this PSP
Evidence No systematic reviews or studies identified
Health Research Classification System category Cancer
Extra information provided by this PSP
Original uncertainty examples Should the clinicians perform biopsies at various time points if one biopsy result shows pleural thickening and fibrosis only?
Comparison Diagnostics
Submitted by Health professional
Outcomes to be measured Diagnosis
PSP information
PSP unique ID 0025
PSP name Mesothelioma
Total number of uncertainties identified by this PSP. 53  (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop 16 December 2014